Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study
Emil Hagström, Stefan James, Maria Bertilsson, et al.
European Heart Journal (2015) Vol. 37, Iss. 16, pp. 1325-1333
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert, Tibor Kempf, Lars Wallentin
Clinical Chemistry (2016) Vol. 63, Iss. 1, pp. 140-151
Open Access | Times Cited: 453
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, et al.
The Lancet (2016) Vol. 387, Iss. 10035, pp. 2302-2311
Closed Access | Times Cited: 445
Novel biomarkers for cardiovascular risk prediction.
Juan Wang, Guo-Juan Tan, Lina Han, et al.
PubMed (2017) Vol. 14, Iss. 2, pp. 135-150
Closed Access | Times Cited: 232
GDF15: A Hormone Conveying Somatic Distress to the Brain
Sam Lockhart, Vladimı́r Saudek, Stephen O’Rahilly
Endocrine Reviews (2020) Vol. 41, Iss. 4
Open Access | Times Cited: 162
Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy
Wael Sumaya, Lars Wallentin, Stefan James, et al.
European Heart Journal (2018) Vol. 39, Iss. 13, pp. 1078-1085
Open Access | Times Cited: 142
Novel Risk Markers and Risk Assessments for Cardiovascular Disease
Mark R. Thomas, Gregory Y.H. Lip
Circulation Research (2017) Vol. 120, Iss. 1, pp. 133-149
Open Access | Times Cited: 130
Novel biomarkers of cardiovascular disease: Applications in clinical practice
Magnus Nakrem Lyngbakken, Peder L. Myhre, Helge Røsjø, et al.
Critical Reviews in Clinical Laboratory Sciences (2018) Vol. 56, Iss. 1, pp. 33-60
Open Access | Times Cited: 121
Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease
Emil Hagström, Claes Held, Ralph Stewart, et al.
Clinical Chemistry (2016) Vol. 63, Iss. 1, pp. 325-333
Open Access | Times Cited: 115
Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
Ziad Hijazi, Jonas Oldgren, Agneta Siegbahn, et al.
Clinical Chemistry (2016) Vol. 63, Iss. 1, pp. 152-164
Closed Access | Times Cited: 94
Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis
Elisa D’Alessandro, Christian Becker, Wolfgang Bergmeier, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 04, pp. 538-564
Open Access | Times Cited: 81
Roles of Growth Differentiation Factor 15 in Atherosclerosis and Coronary Artery Disease
Juan Wang, Liqun Wei, Xinchun Yang, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 17
Open Access | Times Cited: 79
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
Eri Kato, David A. Morrow, Chirk Jenn Ng, et al.
European Heart Journal (2022) Vol. 44, Iss. 4, pp. 293-300
Open Access | Times Cited: 61
Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology
Arantxa González, Mark Richards, Rudolf A. de Boer, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 927-943
Open Access | Times Cited: 51
Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future
Farah Omran, Ioannis Kyrou, Faizel Osman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5680-5680
Open Access | Times Cited: 40
Growth Differentiation Factor-15 Predicts Major Bleeding in Cancer Patients
Cornelia Englisch, Stephan Nopp, Florian Moik, et al.
JACC CardioOncology (2025)
Open Access | Times Cited: 1
Current and novel biomarkers in cardiogenic shock
Victor Galusko, Florian A. Wenzl, Christophe Vandenbriele, et al.
European Journal of Heart Failure (2025)
Open Access | Times Cited: 1
Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome (FRISC-II): 15 year follow-up of a prospective, randomised, multicentre study
Lars Wallentin, Lars Lindhagen, Elisabet Ärnström, et al.
The Lancet (2016) Vol. 388, Iss. 10054, pp. 1903-1911
Closed Access | Times Cited: 79
GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction
Emma Skau, Egil Henriksen, Philippe Wagner, et al.
European Journal of Preventive Cardiology (2017) Vol. 24, Iss. 15, pp. 1576-1583
Closed Access | Times Cited: 70
Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes
Daniel Lindholm, Stefan James, Katja Gabrysch, et al.
JAMA Cardiology (2018) Vol. 3, Iss. 12, pp. 1160-1160
Open Access | Times Cited: 64
Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort
Paul Welsh, Dorien M. Kimenai, Riccardo E. Marioni, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 60, Iss. 11, pp. 1820-1829
Open Access | Times Cited: 34
Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure Management
Khalid Sawalha, Nicholas B. Norgard, Betty M. Drees, et al.
Current Heart Failure Reports (2023) Vol. 20, Iss. 4, pp. 287-299
Closed Access | Times Cited: 16
Growth/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration
Geoffrey Dogon, Eve Rigal, Eliot Potel, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
GDF-15 como Biomarcador em Doenças Cardiovasculares
Bruna Miers May, Maurício Pimentel, Leandro Ioschpe Zimerman, et al.
Arquivos Brasileiros de Cardiologia (2021)
Open Access | Times Cited: 35
Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases
Angelo Michele de Candia, Diane Xavier de Ávila, Gustavo Rodolfo Moreira, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100046-100046
Open Access | Times Cited: 34
Antiplatelet agents for chronic kidney disease
Patrizia Natale, Suetonia C. Palmer, Valeria Saglimbene, et al.
Cochrane library (2022) Vol. 2022, Iss. 2
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top